Advertisement
ENOV vs GMED
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Hold and GMED is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green whileGMED’s FA Score has 0 green FA rating(s).
- ENOV’s FA Score: 0 green, 5 red.
- GMED’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 4 TA indicator(s) are bullish while GMED’s TA Score has 4 bullish TA indicator(s).
- ENOV’s TA Score: 4 bullish, 4 bearish.
- GMED’s TA Score: 4 bullish, 5 bearish.
Price Growth
ENOV (@Medical/Nursing Services) experienced а -0.86% price change this week, while GMED (@Medical/Nursing Services) price change was -4.90% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.78%. For the same industry, the average monthly price growth was +2.20%, and the average quarterly price growth was +14.35%.
Reported Earning Dates
ENOV is expected to report earnings on Feb 26, 2026.
GMED is expected to report earnings on Feb 19, 2026.
Industries' Descriptions
@Medical/Nursing Services (-2.78% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ENOV | GMED | ENOV / GMED | |
| Capitalization | 1.25B | 11.7B | 11% |
| EBITDA | -995.45M | 710M | -140% |
| Gain YTD | -18.206 | 0.160 | -11,354% |
| P/E Ratio | N/A | 28.30 | - |
| Revenue | 2.23B | 2.77B | 81% |
| Total Cash | 33.6M | 391M | 9% |
| Total Debt | 1.44B | 119M | 1,211% |
ENOV | GMED | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 69 | |
SMR RATING 1..100 | 97 | 71 | |
PRICE GROWTH RATING 1..100 | 87 | 41 | |
P/E GROWTH RATING 1..100 | 98 | 99 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GMED's Valuation (74) in the Medical Specialties industry is in the same range as ENOV (78) in the Industrial Machinery industry. This means that GMED’s stock grew similarly to ENOV’s over the last 12 months.
GMED's Profit vs Risk Rating (69) in the Medical Specialties industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that GMED’s stock grew similarly to ENOV’s over the last 12 months.
GMED's SMR Rating (71) in the Medical Specialties industry is in the same range as ENOV (97) in the Industrial Machinery industry. This means that GMED’s stock grew similarly to ENOV’s over the last 12 months.
GMED's Price Growth Rating (41) in the Medical Specialties industry is somewhat better than the same rating for ENOV (87) in the Industrial Machinery industry. This means that GMED’s stock grew somewhat faster than ENOV’s over the last 12 months.
ENOV's P/E Growth Rating (98) in the Industrial Machinery industry is in the same range as GMED (99) in the Medical Specialties industry. This means that ENOV’s stock grew similarly to GMED’s over the last 12 months.
| ENOV | GMED | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 70% | 2 days ago 60% |
| Stochastic ODDS (%) | 2 days ago 58% | 2 days ago 63% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 60% |
| MACD ODDS (%) | 2 days ago 66% | 2 days ago 54% |
| TrendWeek ODDS (%) | 2 days ago 78% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 63% |
| Advances ODDS (%) | 27 days ago 60% | 14 days ago 65% |
| Declines ODDS (%) | 8 days ago 76% | 2 days ago 57% |
| BollingerBands ODDS (%) | 2 days ago 65% | 2 days ago 61% |
| Aroon ODDS (%) | N/A | 2 days ago 55% |
Advertisement
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with FELE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then FELE could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | -1.71% | ||
| FELE - ENOV | 56% Loosely correlated | +0.61% | ||
| IART - ENOV | 56% Loosely correlated | -3.41% | ||
| CNMD - ENOV | 56% Loosely correlated | -1.07% | ||
| DOV - ENOV | 55% Loosely correlated | +2.09% | ||
| PH - ENOV | 53% Loosely correlated | +1.30% | ||
More | ||||
GMED and
Correlation & Price change
A.I.dvisor indicates that over the last year, GMED has been loosely correlated with TMCI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GMED jumps, then TMCI could also see price increases.
| Ticker / NAME | Correlation To GMED | 1D Price Change % | ||
|---|---|---|---|---|
| GMED | 100% | -2.51% | ||
| TMCI - GMED | 45% Loosely correlated | -7.52% | ||
| CTKB - GMED | 44% Loosely correlated | -2.13% | ||
| ENOV - GMED | 44% Loosely correlated | -1.71% | ||
| BRKR - GMED | 44% Loosely correlated | -2.49% | ||
| VREX - GMED | 44% Loosely correlated | -1.62% | ||
More | ||||